Home » Topics » BioWorld

BioWorld
RSS

APPLIED BIO TO ACQUIRE PHARMACO

July 25, 1991

PTO DECLARES ANTISENSING PATENT CONFLICT

July 25, 1991

CENTOCOR'S SEPSIS STUDY COMES UNDER FIRE

July 25, 1991

SYNERGEN REACQUIRES TROFAK RIGHTS

July 24, 1991

NEWS BRIEFS

July 24, 1991

ENZYTECH TO DEVELOP MAb DELIVERY FOR CENTOCOR

July 24, 1991

TRIPLEX COMPLETES $12.2M PRIVATE PLACEMENT

July 24, 1991

CETUS DRUG PORTFOLIO DIFFICULT TO VALUE

July 24, 1991

CETUS TO SELL PCR TECHNOLOGY

July 23, 1991

CHIRON-CETUS MERGER AT A GLANCE

July 23, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026